Navigation Links
Acuo Technologies Updates the Universal Clinical Platform

BLOOMINGTON, Minn., Feb. 21, 2012 /PRNewswire/ -- Acuo Technologies®, the leader in high-performance software and services for intelligent clinical content management and data migration, is pleased to announce the latest release of its award winning Universal Clinical Platform (UCP3).  Version 6.0 adds advanced features required for next generation Vendor Neutral Archive solutions with standards based clinical registry and repository capabilities, unmatched infrastructure versatility, and increased performance and scalability.

AcuoAccess™ and AcuoWorkflow™ are introduced with this release.  These components offer an intelligence layer based on Web Services and RESTful APIs that facilitate enterprise workflow, a comprehensive tag mapping platform with input, output and query support, and access to DICOM and non-DICOM data, including support for the MINT protocol.  "Acuo is pleased to offer next generation capabilities by exposing its enterprise VNA collaboration and orchestration capabilities through Web Services," stated Shannon Werb, Chief Operating Officer.  "This functionality will allow Acuo's customers and partners to experience unprecedented access, control and flexibility – resulting in true data ownership." 

UCP3 introduces enterprise Master Patient Index capabilities, based on the PIX and PDQ IHE actors along with a "plugin" architecture that provides a flexible extension to varying MPI requirements within complex customer and HIE environments.  The cloud enabled solution is further augmented by integrations to third party cloud storage providers such as Nirvanix® and Scality® (based on Amazon S3).

UCP3 version 6.0 enhances non-DICOM support through an innovative enterprise approach based on the IHE XDS.b profile, including and XDS.b Repository and Registry, enabling management of any non-DICOM content in a standard based context.  "Data can be stored and retrieved via the IHE Web Service based transactions or RESTful APIs," stated Razvan Atanasiu, Chief Technical Officer, "this facilitates scalability via streaming and also simplifies the workflow for customers who do not have an IHE infrastructure already deployed.  Acuo has successfully completed the testing of these actors at the 2012 IHE Connectathon and is also proud to announce its participation in the HIMSS IHE Interoperability Showcase."

About Acuo Technologies

Acuo Technologies, with headquarters in Minneapolis, MN, was founded in 2000 with the objective of developing the first enterprise-wide collaborative Universal Clinical Platform (UCP3) solution for medical image content, both DICOM and Non-DICOM. Today, Acuo supports implementations of UCP3 around the world, including locations in Africa, Australia, Canada, New Zealand, South America, United States and the United Kingdom.  For more information on providing superior medical image lifecycle and content management while simplifying operations and reducing costs, visit

DICOM is the registered trademark of the National Electrical Manufacturers Association for its standards publications relating to digital communications of medical information.


SOURCE Acuo Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
3. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
4. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
5. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
6. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
7. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
8. Senesco Technologies Initiates Preclinical Studies for Cancer Target
9. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
10. Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine
11. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
Post Your Comments:
(Date:11/25/2015)... 2015 Developmental, commercial, and regulatory/legal ... profitability of pharmaceutical products, says GBI Research ... regulatory/legal strategies all play a key role in boosting ... . --> Developmental, commercial, ... in boosting the profitability of pharmaceutical products, says ...
(Date:11/24/2015)... NEW DELHI , November 25, 2015 ... fear invoked due to repeated failure of IVF cycles. ... Rani Bhatia was totally dejected and had lost all hopes that ... the first Indian miracle child conceived after failure of ... to abroad (UK) before they decided to take one last ...
(Date:11/24/2015)... HILL, N.C. , Nov. 24, 2015  In ... research projects in an effort to quickly uncover new ... position. --> --> ... launch a market research project and ensure that all ... company and industry standards. Another major barrier to efficiently ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... 25, 2015 , ... In an ongoing Clinical Study conducted by an independent ... UV Angel is evaluating the efficacy of its product and its disinfection protocol. This ... beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical center ...
(Date:11/25/2015)... ... November 25, 2015 , ... "When I underwent breast reconstruction ... incredibly uncomfortable," said an inventor from Bronx, N.Y. "In order to meet my ... RECOVERY BRA for added comfort and support. The bra is easier to put ...
(Date:11/25/2015)... ... ... Since its launch in 2012, the Regenestem brand ( ... to patients with chronic degenerative medical conditions. Now, the U.S. Patent and Trademark ... Organizations are required to hold a registered trademark in order to make licensing ...
(Date:11/24/2015)... ... ... Dr. Todd S. Afferica, a noted general dentist in Norcross, GA ... Afferica now uses the BIOLASE WaterLase iPlus 2.0™ in many of his dental procedures. ... traditional cutting tools, such as the scalpel and high-speed drill, which can both cause ...
(Date:11/24/2015)... ... , ... In an article published November 12th by Obesity News ... or are not eligible for bariatric surgery. The article explains that candidates for weight ... 100 pounds overweight, or have a BMI of 35 and over with at least ...
Breaking Medicine News(10 mins):